Navigation Links
MRSA study demonstrates need for frequent hand washing and environmental disinfection in health care settings

A major cause of hospital-acquired infections can persist for days and even weeks on environmental surfaces found in healthcare settings, including bed linens, computer keyboard covers and acrylic fingernails, according to research presented today at the 105th General Meeting of the American Society for Microbiology.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections in the United States. Staphylococcal infections can cause conditions ranging from mild skin infections to serious surgical wound infections, pneumonia or blood infections.

"The potential of MRSA to be transferred from person to person, in large part, depends on its ability to survive on environmental surfaces," says researcher Kris Owens of Ecolab, Inc. in Mendota Heights, Minnesota.

For the study, two strains of MRSA were inoculated in triplicate onto coupons made of bed linen, keyboard covers and acrylic fingernails. At selected times over 8 weeks, the coupons were subcultured and surviving bacteria were counted. MRSA survivors remained at detectable levels for 8 weeks on acrylic fingernails, 6 weeks on computer keyboard covers and 5 days on bed linen. "The results of this study clearly demonstrate the need for frequent hand washing and environmental disinfection in health care settings," says Owens.


'"/>

Source:ASM


Page: 1

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, ... require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
Breaking Biology Technology: